Share
2,226 Posts.
lightbulb Created with Sketch. 255
clock Created with Sketch. 25/02/21
15:36
Share
Originally posted by SebTaylor:
↑
There's a clearer way forward now .. but watch out for the results announcement next week as it's likely to be a shocker."The delay of the receipt of the final approvals from the MHRA to start the production and saleof Co-Codamol products under the Company’s marketing authorisations into the UK hascaused the Company to generate greater than expected operating losses in the final quarterof 2020 and these losses have continued into the 2021 Year. At present, the business is using approximately $1-2m of cash per month although this number will fluctuate with variationsin API and Contract Manufactured Finished Dosage sales, and domestic poppy straw harvestcommitments "
Expand
I expect substantial losses, negative EBIDTA, new CR or debt, decline of all sales, missed targets ...and of course remuneration increase. What about the litigation process in UK? Their board financial acumen is under stress, yet to proof they know what they are doing. I really doubt it. SP down bellow 60 cents.
